BELITE BIO, INC

Analyst Reco. Belite Bio, Inc

Equities

BLTE

US07782B1044

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
43.2 ^USD	+5.11%		+8.68%	-5.57%

04-26	Belite Bio Unveils Plan to Offer 651,380 American Depository Shares	MT
03-22	Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Belite Bio Unveils Plan to Offer 651,380 American Depository Shares	04-26	MT
Maxim Starts Coverage on Belite Bio with Buy Rating, $60 Price Target	12-14	MT
HC Wainwright Raises Price Target on Belite Bio to $59 From $55, Maintains Buy Rating	11-06	MT
Cantor Fitzgerald Initiates Belite Bio at Overweight Rating With $43 Price Target	23-07-28	MT
SVB Securities Starts Belite Bio at Outperform With $25 Price Target	23-07-26	MT
HC Wainwright Adjusts Belite Bio's Price Target to $55 From $58, Keeps Buy Rating	23-06-05	MT
HC Wainwright Initiates Coverage on Belite Bio With Buy Rating, $58 Price Target	22-08-01	MT
Benchmark Capital Initiates Belite Bio at Buy with $57 Price Target	22-07-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer